Irbesartan [irbesartan]
- Terms
-
2-butyl-3-{[2'-(1H-tetrazol-5-yl)bifenyl-4-yl]methyl}-1,3-diazaspiro[4.4]non-1-en-4-on
Ifirmasta
Irbesartan
Isame
-
2-N-Butyl-3-((2'-(1H-tetrazol-5-yl)biphenyl-4-yl)methyl)-1,3-diazaspiro(4,4)non-1-en-4-one
Aprovel
Avapro
BMS 186295
BMS-186295
Karvea
SR 47436
SR-47436
A spiro compound, biphenyl and tetrazole derivative that acts as an angiotensin II type 1 receptor antagonist. It is used in the management of HYPERTENSION, and in the treatment of kidney disease.
- DUI
- D000077405 MeSH Browser
- CUI
- M0216909
- CAS
- 1,3-Diazaspiro(4.4)non-1-en-4-one, 2-butyl-3-((2'-(1H-tetrazol-5-yl)(1,1'-biphenyl)-4-yl)methyl)-
- History note
- 2019 (1993)
- Public note
- 2019; IRBESARTAN was indexed under BIPHENYL COMPOUNDS and TETRAZOLES 1993-2018
Allowable subheadings
- AD
- administration & dosage 3
- AE
- adverse effects 4
- AG
- agonists
- AA
- analogs & derivatives
- AN
- analysis
- AI
- antagonists & inhibitors
- BL
- blood
- CF
- cerebrospinal fluid
- CS
- chemical synthesis
- CH
- chemistry
- CL
- classification
- EC
- economics
- HI
- history
- IM
- immunology
- IP
- isolation & purification
- ME
- metabolism
- PK
- pharmacokinetics
- PD
- pharmacology
- PO
- poisoning
- RE
- radiation effects
- ST
- standards
- SD
- supply & distribution
- TU
- therapeutic use 2
- TO
- toxicity
- UR
- urine